| Name: Endpoints Met in First Stage of ADVENTRX CoFactor Phase II Metastatic Colorectal Cancer Study; Patient Enrollment
Description: 5-FU) in patients with metastatic colorectal cancer. The Company further announced that and overall survival in metastatic colorectal cancer patients treated with CoFactor and
Category: Metastatic Colorectal Cancer
Url: http://www.freshnews.com/news/biotech-biomedical/article_21375.html
Date: Oct 7, 2005
Current Rating: 0.00
Clicks/Hits Received: 0 |
|